These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2892688)

  • 1. Autoradiographic localization of dopamine D1 binding sites in areas receiving striatal input.
    Graham WC; Crossman AR
    Eur J Pharmacol; 1987 Oct; 142(3):479-81. PubMed ID: 2892688
    [No Abstract]   [Full Text] [Related]  

  • 2. Guanine nucleotide regulation of agonist interactions at [3H]SCH23390-labeled D1 dopamine receptors in rat striatum.
    Hess EJ; Battaglia G; Norman AB; Iorio LC; Creese I
    Eur J Pharmacol; 1986 Feb; 121(1):31-8. PubMed ID: 2869957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Striatal D1 dopamine receptor distribution following chemical lesion of the nigrostriatal pathway.
    Ariano MA
    Brain Res; 1988 Mar; 443(1-2):204-14. PubMed ID: 2965958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative activities of SCH 23390 and its analogs in three tests for D1/DA1 dopamine receptor antagonism.
    Barnett A; Ahn HS; Billard W; Gold EH; Kohli JD; Glock D; Goldberg LI
    Eur J Pharmacol; 1986 Sep; 128(3):249-53. PubMed ID: 2878816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic neuroleptic treatment increases D-2 but not D-1 receptors in rat striatum.
    MacKenzie RG; Zigmond MJ
    Eur J Pharmacol; 1985 Jul; 113(2):159-65. PubMed ID: 2864265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased striatal D1 binding density following mesotelencephalic 6-hydroxydopamine injections: an autoradiographic analysis.
    Marshall JF; Navarrete R; Joyce JN
    Brain Res; 1989 Jul; 493(2):247-57. PubMed ID: 2527583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dopamine D1 receptor: biochemical and behavioral aspects.
    Andersen PH; Nielsen EB
    Adv Exp Med Biol; 1986; 204():73-91. PubMed ID: 2878580
    [No Abstract]   [Full Text] [Related]  

  • 8. Similarity of age-dependent changes in renal and striatal dopamine receptors.
    Mancini M; Ricci A; Zaccheo D; Amenta F
    Funct Neurol; 1991; 6(3):227-9. PubMed ID: 1835951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective D-1 dopamine receptor increase following chronic treatment with SCH 23390.
    Creese I; Chen A
    Eur J Pharmacol; 1985 Feb; 109(1):127-8. PubMed ID: 2859993
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of the enantiomers of SK&F 83566 as specific and stereoselective antagonists at the striatal D-1 dopamine receptor: comparisons with the D-2 enantioselectivity of Ro 22-1319.
    O'Boyle KM; Waddington JL
    Eur J Pharmacol; 1984 Oct; 106(1):219-20. PubMed ID: 6241567
    [No Abstract]   [Full Text] [Related]  

  • 11. D-1 dopamine receptors in the rat brain: autoradiographic localization using [3H]SCH 23390.
    Dawson TM; Gehlert DR; Yamamura HI; Barnett A; Wamsley JK
    Eur J Pharmacol; 1985 Feb; 108(3):323-5. PubMed ID: 3886408
    [No Abstract]   [Full Text] [Related]  

  • 12. Striatal D1- and D2-dopamine receptor sites are separately detectable in vivo.
    Leslie CA; Bennett JP
    Brain Res; 1987 Jul; 415(1):90-7. PubMed ID: 2957025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D1 receptor in rat brain: a quantitative autoradiographic study with 125I-SCH 23982.
    Aiso M; Shigematsu K; Kebabian JW; Potter WZ; Cruciani RA; Saavedra JM
    Brain Res; 1987 Apr; 408(1-2):281-5. PubMed ID: 2954614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D-1 dopamine receptor changes after striatal quinolinic acid lesion.
    Barone P; Tucci I; Parashos SA; Chase TN
    Eur J Pharmacol; 1987 Jun; 138(1):141-5. PubMed ID: 2957219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of binding of 3H-SCH-23390 to D-1 dopaminergic receptor sites in rat striatal tissue.
    Faedda G; Kula NS; Baldessarini RJ
    Biochem Pharmacol; 1989 Feb; 38(3):473-80. PubMed ID: 2563653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain D1 dopamine receptor in alloxan-induced diabetes.
    Salković M; Lacković Z
    Diabetes; 1992 Sep; 41(9):1119-21. PubMed ID: 1386820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ; Marshall JF
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. I. 6-OHDA lesions of ascending mesencephalic dopaminergic pathways in the rat.
    Graham WC; Crossman AR; Woodruff GN
    Brain Res; 1990 Apr; 514(1):93-102. PubMed ID: 2113410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral and biochemical expression of D1-receptor supersensitivity following SCH 23390 repeated administrations.
    Gandolfi O; Roncada P; Dall'Olio R; Montanaro N
    Brain Res; 1988 Jul; 455(2):390-3. PubMed ID: 2969768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective blockade of dopamine D-1 receptors by SCH 23390 discloses striatal dopamine D-2 receptors mediating the inhibition of adenylate cyclase in rats.
    Onali P; Olianas MC; Gessa GL
    Eur J Pharmacol; 1984 Mar; 99(1):127-8. PubMed ID: 6233165
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.